Authors:
Jourdan, E
Reiffers, J
Stoppa, AM
Sotto, JJ
Attal, M
Bouabdallaha, R
Marit, G
Fegueux, N
Boulat, O
Dastugue, N
Boiron, JM
Faberes, C
Gastaut, JA
Maraninchi, D
Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Authors:
Bouabdallah, R
Stoppa, AM
Coso, D
Bardou, VJ
Blaise, D
Chabannon, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Authors:
Brenot-Rossi, I
Bouabdallah, R
Di Stefano, D
Bardou, VJ
Stoppa, AM
Camerlo, J
Sauvan, R
Gastaut, JA
Pasquier, J
Citation: I. Brenot-rossi et al., Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy, EUR J NUCL, 28(10), 2001, pp. 1482-1488
Authors:
Blaise, D
Attal, M
Reiffers, J
Michallet, M
Bellanger, C
Pico, JL
Stoppa, AM
Payen, C
Marit, G
Bouabdallah, R
Sotto, JJ
Rossi, JF
Brandely, M
Hercend, T
Maraninchi, D
Citation: D. Blaise et al., Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission, EUR CYTOKIN, 11(1), 2000, pp. 91-97
Authors:
Reynaud-Gaubert, M
Stoppa, AM
Gaubert, JY
Thomas, P
Fuentes, P
Citation: M. Reynaud-gaubert et al., Anti-CD20 monoclonal antibody therapy in Epstein-Barr virus-associated B cell lymphoma following lung transplantation, J HEART LUN, 19(5), 2000, pp. 492-495
Authors:
Milpied, N
Vasseur, B
Parquet, N
Garnier, JL
Antoine, C
Quartier, P
Carret, AS
Bouscary, D
Faye, A
Bourbigot, B
Reguerre, Y
Stoppa, AM
Bourquard, P
de Ligny, BH
Dubief, F
Mathieu-Boue, A
Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Authors:
Fenaux, P
Chevret, S
Guerci, A
Fegueux, N
Dombret, H
Thomas, X
Sanz, M
Link, H
Maloisel, F
Gardin, C
Bordessoule, D
Stoppa, AM
Sadoun, A
Muus, P
Wandt, H
Mineur, P
Whittaker, JA
Fey, M
Daniel, MT
Castaigne, S
Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
Authors:
Mohty, M
Faucher, C
Vey, N
Stoppa, AM
Viret, F
Chabbert, I
Chabannon, C
Bouabdallah, R
Ladaique, P
Collet, L
Zandotti, C
Maraninchi, D
Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255
Authors:
Gravis, G
Viens, P
Vey, N
Blaise, D
Stoppa, AM
Olive, D
Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991
Authors:
Vey, N
Blaise, D
Lafage, M
Olive, D
Viens, P
Baume, D
Camerlo, J
Stoppa, AM
Gabus, R
Brandely, M
Hercend, T
Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181
Authors:
Olivero, S
Novakovitch, G
Ladaique, P
Sainty, D
Viret, F
Faucher, C
Stoppa, AM
Blaise, D
Chabannon, C
Citation: S. Olivero et al., T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells, CYTOTHERAPY, 1(6), 1999, pp. 469-477
Authors:
Viret, F
Blaise, D
Bouabdallah, R
Stoppa, AM
Novakovitch, G
Faucher, C
Vey, N
Camerlo, J
Oziel-Taieb, S
Ladaique, P
Gastaut, JA
Maraninchi, D
Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Authors:
Thomas, X
Fenaux, P
Dombret, H
Delair, S
Dreyfus, F
Tilly, H
Vekhoff, A
Cony-Makhoul, P
Leblond, V
Troussard, X
Cordonnier, C
de Revel, T
Simon, M
Nicolini, F
Stoppa, AM
Janvier, M
Bordessoule, D
Rousselot, P
Ffrench, M
Marie, JP
Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220
Authors:
Bouabdallah, R
Stoppa, AM
Rossi, JF
Lepeu, G
Coso, D
Xerri, L
Ladaique, P
Chabannon, C
Blaise, D
Bardou, VJ
Alzieu, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Authors:
Gahrton, G
Svensson, H
Bjorkstrand, B
Apperley, J
Carlson, K
Cavo, M
Ferrant, A
Fouillard, L
Gratecos, N
Gratwohl, A
Guilhot, F
Deliliers, GL
Ljungman, P
Masszi, T
Milligan, DW
Powles, RL
Reiffers, J
Samson, JD
Stoppa, AM
Vernant, JP
Volin, L
Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Authors:
Viret, F
Chabannon, C
Aurran-Schleinitz, T
Reviron, D
Stoppa, AM
Faucher, C
Ladaique, P
Gastaut, JA
Maraninchi, D
Blaise, D
Citation: F. Viret et al., Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD, BONE MAR TR, 24(2), 1999, pp. 225-227
Authors:
Xerri, L
Devilard, E
Bouabdallah, R
Stoppa, AM
Hassoun, J
Birg, F
Citation: L. Xerri et al., FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis, BR J HAEM, 106(3), 1999, pp. 652-661
Authors:
Maraninchi, D
Vey, N
Viens, P
Stoppa, AM
Archimbaud, E
Attal, M
Baume, D
Bouabdallah, R
Demeoq, F
Fleury, J
Michallet, M
Olive, D
Reiffers, J
Sainty, D
Tabilio, A
Tiberghien, P
Brandely, M
Hercend, T
Blaise, D
Citation: D. Maraninchi et al., A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 343-349